{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:00Z","timestamp":1786649520607,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Thyroid auto-antibodies could be one of the many causes of infertility in women, especially with polycystic ovarian syndrome (PCOS) with a prevalence of 5%\u201315%. Patients with anti-thyroid antibodies have shown significantly lower fertilisation rates, implantation rates, lower pregnancy rates and increased risk of first-trimester abortions when compared with those without anti-thyroid antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of the study was to assess the prevalence of thyroid auto-antibodies in euthyroid infertile women with PCOS and to compare the prevalence of thyroid autoantibodies in euthyroid infertile women with PCOS and without PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This is a cross sectional analytical study involving 132 Infertile women with and without PCOS visiting the department of OBG in a tertiary care center. The study was conducted for period of 2 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of one hundred two women were enrolled in to the study. Sixty six women (66) had features of PCOS based on Rotterdam\u2019s criteria and 66 women were controls without PCOS features. Detailed history and examination were done for all women after taking informed and written consent. Previous hospital records were collected along with all biochemical investigations. The blood sample was collected for hormonal levels and thyroid auto-antibodies (anti-thyroid peroxidase [TPO] and anti-thyroglobulin [TG]) were assessed by enzyme-linked immunosorbent assay. The antibody levels were compared between the two groups along with the other parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Statistical tests were done using SPSS version 26. The Chi-square test or Fisher\u2019s exact test would be used to study the association of categorical data like the presence of hirsutism, acne, etc. The association of independent variables with outcome variables was assessed using Chi-square. The P &lt; 0.05 was considered significant with a confidence interval of 95%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Anti-TPO antibody levels were found to be elevated in 25.4% of the PCOS group in comparison to only 3% of the non-PCOS group. Anti-TG antibodies of &gt;100 U\/mL were seen in 23 patients (34.3%) in PCOS group in comparison to two patients (3%) in non-PCOS group (P = 0.001). Both the antibodies (anti-TPO and anti-TG) were present in 21.2% of the PCOS group and 1.5% of the non-PCOS group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Women with PCOS were found to be 11 times more likely to have anti-TPO antibodies and 20 times more likely to have anti-TG antibodies compared to non-PCOS women. This heightened prevalence of anti-thyroid antibodies suggests that testing for these antibodies may be warranted in women with PCOS, even if they have normal thyroid function. However, further studies with larger sample sizes are needed to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_155_24","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:01:14Z","timestamp":1735016474000},"page":"269-274","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of Thyroid Auto-antibodies in Euthyroid Infertile Women with Polycystic Ovarian Syndrome - A Cross-sectional Analytical Study"],"prefix":"10.4103","volume":"17","author":[{"given":"K. H.","family":"Anusha","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Thyagaraju","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nandeesha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/105072502320908330","article-title":"Thyroid dysfunction and autoimmunity in infertile women","volume":"12","author":"Poppe","year":"2002","journal-title":"Thyroid"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/09513590.2012.705391","article-title":"Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity","volume":"29","author":"Artini","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/oxfordjournals.humrep.a135745","article-title":"Autoimmune disorders:Another possible cause for in-vitro fertilization and embryo transfer failure","volume":"10","author":"Geva","year":"1995","journal-title":"Hum Reprod"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0002-9378(12)90830-3","article-title":"Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss","volume":"168","author":"Pratt","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4274\/jtgga.2016.0217","article-title":"Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome","volume":"18","author":"Karak\u00f6se","year":"2017","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"R6-20241224","first-page":"215","article-title":"The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome","volume":"19","author":"Hep\u015fen","year":"2018","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/humrep\/dev073","article-title":"Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome","volume":"30","author":"Sam","year":"2015","journal-title":"Hum Reprod"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10815-008-9284-4","article-title":"Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: A randomized prospective clinical trial","volume":"26","author":"Ganesh","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fendo.2019.00656","article-title":"Anti-m\u00fcllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome","volume":"10","author":"Abbara","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20241224","doi-asserted-by":"crossref","first-page":"62","DOI":"10.18231\/j.ijcbr.2021.013","article-title":"Study of TSH and prolactin in PCOS subjects: A case control study","volume":"8","author":"Latha","year":"2021","journal-title":"Int J Clin Biochem Res"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3329\/bmj.v45i1.28957","article-title":"Association of altered thyroid function and prolactin level in polycystic ovarian syndrome","volume":"45","author":"Mustari","year":"2016","journal-title":"Bangladesh Med J"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179558119871921","article-title":"PCOS and hyperprolactinemia: What do we know in 2019?","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"R13-20241224","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","article-title":"High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome","volume":"169","author":"Garelli","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20241224","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-73-4-811","article-title":"Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease","volume":"73","author":"Fauser","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20241224","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0974-1208.178636","article-title":"Endocrinal and autoimmune linkage:Evidences from a controlled study of subjects with polycystic ovarian syndrome","volume":"9","author":"Arora","year":"2016","journal-title":"J Hum Reprod Sci"},{"key":"R16-20241224","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13224-016-0914-y","article-title":"Antithyroid peroxidase antibodies in women with polycystic ovary syndrome","volume":"67","author":"Menon","year":"2017","journal-title":"J Obstet Gynaecol India"},{"key":"R17-20241224","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/2230-8210.109714","article-title":"Thyroid disorders in polycystic ovarian syndrome subjects:A tertiary hospital based cross-sectional study from Eastern India","volume":"17","author":"Sinha","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"R18-20241224","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1530\/EC-18-0309","article-title":"Association between PCOS and autoimmune thyroid disease:A systematic review and meta-analysis","volume":"7","author":"Romitti","year":"2018","journal-title":"Endocr Connect"},{"key":"R19-20241224","first-page":"381","article-title":"Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases","volume":"38","author":"van Gelderen","year":"1993","journal-title":"J Reprod Med"},{"key":"R20-20241224","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2010.06.008","article-title":"Polycystic ovary syndrome and autoimmunity","volume":"21","author":"Petr\u00edkov\u00e1","year":"2010","journal-title":"Eur J Intern Med"},{"key":"R21-20241224","doi-asserted-by":"crossref","first-page":"J109","DOI":"10.1016\/j.jaut.2011.10.003","article-title":"Autoimmune disease and gender: Plausible mechanisms for the female predominance of autoimmunity","volume":"38","author":"Quintero","year":"2012","journal-title":"J Autoimmun"},{"key":"R22-20241224","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R23-20241224","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fendo.2020.00440","article-title":"Ovarian reserve and serum concentration of thyroid peroxidase antibodies in euthyroid women with different polycystic ovary syndrome phenotypes","volume":"11","author":"Adamska","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R24-20241224","doi-asserted-by":"crossref","first-page":"e12427","DOI":"10.1002\/rmb2.12427","article-title":"Effect of hypothyroidism and thyroid autoimmunity on the ovarian reserve:A systematic review and meta-analysis","volume":"21","author":"Hasegawa","year":"2022","journal-title":"Reprod Med Biol"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_155_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:58Z","timestamp":1786647298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_155_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_155_24","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-10-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}